XML 60 R45.htm IDEA: XBRL DOCUMENT v3.25.1
Investments in Unconsolidated Joint Ventures (Statements of Operations of the Joint Ventures) (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Schedule of Equity Method Investments [Line Items]    
Total revenue $ 865,215 $ 839,439
Expenses    
Transaction costs 768 513
Depreciation and amortization 220,107 218,716
Total expenses 616,801 593,712
Other income (expense)    
Loss from early extinguishment of debt (338) 0
Interest expense (163,444) (161,891)
Net Income (Loss) 86,905 106,604
Income (loss) from unconsolidated joint ventures (2,139) 19,186
Unconsolidated Joint Ventures [Member]    
Schedule of Equity Method Investments [Line Items]    
Total revenue [1] 130,687 130,392
Expenses    
Operating 53,729 49,194
Transaction costs 170 2
Depreciation and amortization 42,379 39,424
Total expenses 96,278 88,620
Other income (expense)    
Loss from early extinguishment of debt (62) 0
Interest expense (44,432) (43,563)
Unrealized gain (loss) on derivative instruments (8,325) 10,112
Net Income (Loss) (18,410) 8,321
Company's share of net income (loss) (5,796) 2,960
Gain on sale / consolidation 0 21,696
Basis differential [2] 3,657 (5,470)
Income (loss) from unconsolidated joint ventures (2,139) 19,186
Straight Line Rent Adjustments 3,400 7,700
Unconsolidated Joint Ventures [Member] | Basis Differential    
Expenses    
Depreciation and amortization (1,400) 2,900
Other income (expense)    
Unrealized gain (loss) on derivative instruments $ (2,200) $ 2,700
[1] Includes straight-line rent adjustments of approximately $3.4 million and $7.7 million for the three months ended March 31, 2025 and 2024, respectively.
[2] Includes depreciation and amortization of approximately $(1.4) million and $2.9 million for the three months ended March 31, 2025 and 2024, respectively. Includes unrealized gain (loss) on derivative instruments of approximately $(2.2) million and $2.7 million for the three months ended March 31, 2025 and 2024, respectively.